- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05216406
Effects of Daily Supplementation of 5-HTP on Body Composition
Effects of Daily Supplementation of 5-HTP on Body Composition, a Randomized Investigation
The purpose of this investigation was to compare supplementation with 5-HTP to placebo on indices of body composition. A randomized trial compared a sample of 48 resistance-trained individuals taking either 100 mg of 5-hydroxytryptophan supplementation or a placebo.
The investigators tested anthropometric measurements using a multi-frequency bioelectrical impedance device (InBody® 270). The primary outcome (i.e., changes in anthropometric measurements) was assessed at the first visit (pre-test-) and post-test (8 weeks). Secondary outcomes include resting heart rate, blood pressure, and dietary intake.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Boca Raton, Florida, United States, 33432
- IHP
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Healthy or free of disease
- Minimum of 1 year of regular physical activity. Regular physical activity is defined by a minimum of 150 minutes of aerobic activity or performing muscle-strengthening exercises at least 2 days a week.
Exclusion Criteria:
- Physically inactive
- Regularly used sleep aids of any kind
- Currently taking selective serotonin reuptake inhibitors (SSRIs) and/or 5-HTP containing supplements.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 5-HTP
The dietary supplement (100 mg of 5-hydroxytryptophan; CLEANMOOD™) was provided by NURA™ (Irvine, California USA).
Subjects were instructed to consume one capsule daily at their convenience for 8 weeks.
|
CLEANMOOD is an organic 5-Hydroxytryptophan (5-HTP) ingredient.
Other Names:
|
|
Placebo Comparator: Control
The placebo consisted of maltodextrin.
Subjects were instructed to consume one capsule daily at their convenience for 8 weeks.
|
Maltodextrin capsule
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body Composition
Time Frame: 8 weeks
|
The percentage of fat, bone, and muscle was assessed pre and post visit using multi-frequency bioelectrical impedance device (InBody® 270).
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dietary Habits
Time Frame: 8 weeks
|
The mobile app MyFitnessPal was used to assess dietary intake.
Subjects were instructed to log their food intake MyFitnessPal, for a minimum of 2-3 days per week during the entire study.
|
8 weeks
|
|
Resting Heart Rate
Time Frame: 8 weeks
|
Resting heart rate will be measured pre and post visit using an upper arm blood pressure monitor and cuff.
|
8 weeks
|
|
Blood Pressure
Time Frame: 8 weeks
|
Systolic and diastolic blood pressure will be measured during pre and post visit using an upper arm blood pressure monitor and cuff.
|
8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jose Antonio, PhD, Nova Southeastern University
Publications and helpful links
General Publications
- Stamatakis E, Straker L, Hamer M, Gebel K. The 2018 Physical Activity Guidelines for Americans: What's New? Implications for Clinicians and the Public. J Orthop Sports Phys Ther. 2019 Jul;49(7):487-490. doi: 10.2519/jospt.2019.0609.
- Maffei ME. 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int J Mol Sci. 2020 Dec 26;22(1):181. doi: 10.3390/ijms22010181.
- Cangiano C, Ceci F, Cairella M, Cascino A, Del Ben M, Laviano A, Muscaritoli M, Rossi-Fanelli F. Effects of 5-hydroxytryptophan on eating behavior and adherence to dietary prescriptions in obese adult subjects. Adv Exp Med Biol. 1991;294:591-3. doi: 10.1007/978-1-4684-5952-4_73. No abstract available.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 102
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Body Composition
-
Efforia, IncRecruiting
-
Dynamical Business and Science Society - DBSS International...Universidad de Córdoba; CES University; ARTHROS Centro de Fisioterapia y EjercicioRecruiting
-
Centro Universitario de Ciencias de la Salud, MexicoCompleted
-
University of Southern CaliforniaCompleted
-
University of California, San FranciscoHologic, Inc.Completed
-
University of SurreyUnknownBody Composition
-
Texas Woman's UniversityCompleted
-
Efforia, IncRecruiting
-
Efforia, IncRecruiting
-
Universidad de ZaragozaCompleted
Clinical Trials on 5-HTP
-
National University, SingaporeCompletedSleep | Gut MicrobiomeSingapore
-
Karolinska InstitutetCompletedThrombosis | Vascular Function | Microcirculation | Heated Tobacco Products | Blood Markers | Microvesicles | NETsSweden
-
Benedictine UniversityUnknown
-
University Hospital, GhentCompletedFatigue | Crohn Disease | Ulcerative Colitis | RemissionBelgium
-
Istituto Clinico HumanitasWithdrawnPancreatic Cancer | Pancreatic Adenocarcinoma | Pancreas NeoplasmItaly
-
Medical University of South CarolinaCompleted
-
University of UtahCompleted
-
University of OregonCompleted
-
University of UtahRecruiting
-
University of Campania Luigi VanvitelliUniversita degli Studi di Napoli FedericoNot yet recruiting